【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 8
1.1 List of Tables 15
1.2 List of Figures 20
2 Introduction 22
2.1 Catalyst 22
2.2 Related Reports 23
2.3 Upcoming Related Reports 23
3 Disease Overview 24
3.1 Etiology and Pathophysiology 24
3.1.1 Etiology 24
3.1.2 Pathophysiology 25
3.1.3 Prognosis and Quality of Life 27
3.2 Symptoms 29
3.2.1 Hemophilia A and B 29
3.2.2 Inhibitors 30
4 Epidemiology 31
4.1 Disease Background 31
4.2 Risk Factors and Comorbidities 32
4.2.1 Almost 50% of hemophilia patients are affected by hypertension 33
4.3 Global Trends 34
4.4 Epidemiological Forecast of Hemophilia (2012-2022) 36
4.4.1 Forecast Methodology 36
4.4.2 Sources Used 37
4.4.3 Sources Not Used 38
4.4.4 Forecast Assumptions and Methods 38
4.5 Epidemiology Forecast (2012-2022), Hemophilia A 43
4.5.1 Diagnosed Prevalent Cases of Hemophilia A 43
4.5.2 Diagnosed Prevalent Cases of Hemophilia A by Age 45
4.5.3 Diagnosed Prevalent Cases of Hemophilia A by Sex 47
4.5.4 Age-Standardized Prevalence of Diagnosed Hemophilia A 48
4.6 Epidemiology Forecast (2012-2022), Hemophilia B 50
4.6.1 Diagnosed Prevalent Cases of Hemophilia B 50
4.6.2 Diagnosed Prevalent Cases of Hemophilia B by Age 52
4.6.3 Diagnosed Prevalent Cases of Hemophilia B by Sex 54
4.6.4 Age-Standardized Prevalence of Diagnosed Hemophilia B 56
4.7 Epidemiology Forecast (2012-2022), Hemophilia A and B 57
4.7.1 Diagnosed Prevalent Cases of Hemophilia A and B 57
4.7.2 Diagnosed Prevalent Cases of Hemophilia A and B by Sex 59
4.8 Discussion 61
4.8.1 Conclusions on Epidemiological Trends 61
4.8.2 Limitations of the Analysis 62
4.8.3 Strengths of the Analysis 63
5 Disease Management 64
5.1 Treatment Overview 64
5.1.1 Hemophilia A and B Diagnosis 65
5.1.2 Hemophilia A and B Treatment 65
5.1.3 Inhibitors Diagnosis 67
5.1.4 Inhibitors Treatment 67
5.2 US 69
5.2.1 Clinical Practice 69
5.3 France 72
5.3.1 Clinical Practice 72
5.4 Germany 74
5.4.1 Clinical Practice 74
5.5 Italy 76
5.5.1 Clinical Practice 76
5.6 Spain 78
5.6.1 Clinical Practice 78
5.7 UK 80
5.7.1 Clinical Practice 80
5.8 Japan 82
5.8.1 Clinical Practice 82
5.9 Argentina 84
5.9.1 Clinical Practice 84
5.10 China 86
5.10.1 Clinical Practice 86
6 Competitive Assessment 88
6.1 Overview 88
6.2 Strategic Competitive Assessment 89
6.3 Product Profiles – Major Brands, Hemophilia A 93
6.3.1 Advate (octocog alfa; Antihemophilic Factor [Recombinant] Plasma/Albumin-Free) 93
6.3.2 Kogenate FS/Helixate FS (Antihemophilic Factor (Recombinant)) 98
6.3.3 Xyntha/ReFacto AF (moroctocog alfa; Antihemophilic Factor [Recombinant], Plasma/Albumin-Free) 103
6.3.4 Recombinate (octocog alfa; Antihemophilic Factor [Recombinant] Plasma/Albumin-Free) 107
6.4 Product Profiles – Hemophilia B 110
6.4.1 BeneFIX (nonacog alfa; coagulation factor IX [recombinant]) 110
6.4.2 Rixubis (BAX-326) 115
6.5 Product Profiles – Hemophilia A and B with Inhibitors 120
6.5.1 NovoSeven RT (coagulation factor VIIa [recombinant]) 120
7 Opportunity and Unmet Need 123
7.1 Overview 123
7.2 Opportunities Analysis 124
7.2.1 Longer-Lasting Recombinant Factors to Reduce the Frequency of Prophylactic Injections 124
7.2.2 Lower-Cost Recombinant Replacement Therapies 125
7.2.3 Lower Risk of Inhibitor Formation in Previously Untreated Patients 126
7.2.4 More Convenient Drug Administration 126
7.2.5 Oral Formulation of Recombinant Replacement Therapies 127
7.3 Unmet Needs Gap Analysis 128
7.3.1 Long-Acting FVIII Replacement Therapies 128
7.3.2 Gene Therapy Treatments for Hemophilia A and B 128
8 Pipeline Assessment 129
8.1 Overview 129
8.2 Clinical Trial Mapping 129
8.2.1 Clinical Trials by Country 129
8.3 Clinical Trials by Phase and Trial Status 130
8.4 Promising Drugs in Clinical Development – Hemophilia A 131
8.4.1 Eloctate (rFVIII-Fc) (recombinant factor VIII fusion protein) 133
8.4.2 BAY 94-9027 (octocog alfa) 140
8.4.3 BAX-855 145
8.4.4 Novoeight (turoctocog alfa; NN7008) 150
8.4.5 N8-GP (NN7088) 155
8.4.6 CSL-627 (rFVIII-SC) 160
8.4.7 Hcl-rhFVIII 165
8.5 Promising Drugs in Clinical Development – Hemophilia B 170
8.5.1 Alprolix (rFIXFc) 172
8.5.2 CSL-654 (rIX-FP) 177
8.5.3 N9-GP (NN-7999) 182
8.5.4 IB1001 (trenacog alfa) 187
8.6 Promising Drugs in Clinical Development – Hemophilia A and B Patients with Inhibitors 192
8.6.1 BAX-817 (rFVIIa BI) 192
9 Current and Future Players 197
9.1 Overview 197
9.2 Trends in Corporate Strategy 199
9.3 Company Profiles 200
9.3.1 Baxter 200
9.3.2 Biogen Idec 204
9.3.3 Novo Nordisk 206
9.3.4 CSL Behring 209
9.3.5 Bayer 210
9.3.6 Pfizer 212
10 Market Outlook 214
10.1 Global Markets 214
10.1.1 Forecast 214
10.1.2 Drivers and Barriers – Global Issues 218
10.2 US 221
10.2.1 Forecast 221
10.2.2 Key Events 225
10.2.3 Drivers and Barriers 225
10.3 France 228
10.3.1 Forecast 228
10.3.2 Key Events 231
10.3.3 Drivers and Barriers 231
10.4 Germany 233
10.4.1 Forecast 233
10.4.2 Key Events 236
10.4.3 Drivers and Barriers 236
10.5 Italy 238
10.5.1 Forecast 238
10.5.2 Key Events 241
10.5.3 Drivers and Barriers 241
10.6 Spain 243
10.6.1 Forecast 243
10.6.2 Key Events 246
10.6.3 Drivers and Barriers 246
10.7 UK 248
10.7.1 Forecast 248
10.7.2 Key Events 251
10.7.3 Drivers and Barriers 251
10.8 Japan 254
10.8.1 Forecast 254
10.8.2 Key Events 257
10.8.3 Drivers and Barriers 257
10.9 Argentina 259
10.9.1 Forecast 259
10.9.2 Key Events 263
10.9.3 Drivers and Barriers 263
10.10 China 266
10.10.1 Forecast 266
10.10.2 Key Events 269
10.10.3 Drivers and Barriers 269
11 Appendix 271
11.1 Bibliography 271
11.2 Abbreviations 287
11.3 Methodology 290
11.4 Forecasting Methodology 290
11.4.1 Diagnosed Hemophilia Patients 291
11.4.2 Percent Drug-Treated Patients 291
11.4.3 Drugs Included in Each Therapeutic Class 291
11.4.4 Launch and Patent Expiry Dates 292
11.4.5 General Pricing Assumptions 293
11.4.6 Individual Drug Assumptions 294
11.4.7 Pricing of Pipeline Agents 298
11.5 Physicians and Specialists Included in this Study 299
11.6 About the Authors 301
11.6.1 Authors 301
11.6.2 Epidemiologists 302
11.6.3 Global Head of Healthcare 303
11.7 About GlobalData 304
11.8 Disclaimer 304
【レポート販売概要】
■ タイトル：血友病A及びB：世界市場（医薬品市場予測及び分析～2022）■ 英文：PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022
■ 発行日：2013年11月30日
■ 調査会社：GlobalData
■ 商品コード：GDATA403162999
■ 調査対象地域：グローバル
- 小動物向け画像診断機器（イン・ビトロ）の世界市場予測（～2021年）：光学イメージング、PET、SPECT、CT、MRI、超音波、光音響画像化装置、磁気粒子画像装置The global small animal imaging market is expected to reach a value of USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016-2021. A number of factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researche …
- 香り付きキャンドルの世界市場2017-2021About Scented Candles Scented candles refer to candles that have synthetic or natural scented material blended into them to provide a pleasant smell while burning. Scented candles provide a relaxing environment as a result of the fragrances released while burning. The high sales of scented candles can be attributed to a rapid surge in internet penetration, which has helped connect sellers and buye …
- スポーツ用品用複合材料の世界市場：炭素繊維、ガラス繊維、その他The global market size of composites-based sporting goods, in terms of value, is projected to reach USD 3.75 Billion by 2021, registering a CAGR of 5.59% between 2016 and 2021. The increasing number of patents filed for composites-based sporting goods by global players, growing manufacturing industries, and continuous new product launches, agreements, and expansion activities undertaken by compani …
- 世界の油田レンタル市場Rising oil & gas prices and increasing drilling activity will drive the global oilfield equipment rental (oilfield rental) market to $46.8 billion by 2018. North America, with its increased focus on unconventional shale plays and keen oil & gas industry, is expected to experience highest revenue growth during the next five years. The factors driving growth in the OER market are increasing drilling …
- 尿検査の世界市場：検尿ディップスティック、検尿試薬、尿分析装置、POC機器The global urinalysis market includes product type, test type, applications, and end user. A number of factors, such as the rising prevalence of kidney diseases and urinary tract infections, implementation of the Patient Protection and Affordable Care Act (PPACA) in the U.S., technological advancements, growing healthcare expenditure in various countries, and rising geriatric population are expect …
- ネットワーク管理ソフトウェアの世界市場2017-2021ABSTRACTAbout Network Management Software NMS manages computer networks over a wide range of network devices and software. It monitors, controls, configures, troubleshoots, plans, allocates, deploys, and coordinates network-based business operations in network devices. The software also enables network managers to supervise individual components within a network management framework spread across …
- 中耳炎(Otitis Media)の治療薬パイプライン動向（2015年上半期版）Otitis Media - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Otitis Media - Pipeline Review, H1 2015’, provides an overview of the Otitis Media’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Otitis Media, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), ro …
- トップ10医療機器技術の世界市場The global top 10 medical device technologies market is estimated to reach USD 428.97 Billion by 2020, growing at a CAGR of 5.5% during the forecast period (2015 to 2020). This market is mainly driven by the rising prevalence of chronic diseases and related increase in disability-adjusted life years (DALYs), technological advancements in medical devices, and growing aging population. The increasin …
- 世界のデジタルX線装置（医療機器）市場（～2018）The global digital X-ray market is categorized on the basis of application, technology, portability, product, end user, price, and geography. The mammography market is expected to register the highest growth rate in the digital X-ray market by application, during the forecast period. This high growth is attributed to technological advancements and the rising incidences of breast cancer .Chest imag …
- スマート衣類の世界市場予測（～2024年）“Smart clothing market to grow at CAGR of 26.2% from 2019 to 2024.” The smart clothing market is likely to grow from USD 1.6 billion in 2019 to USD 5.3 billion by 2024, at a CAGR of 26.2%. The growth of this market is driven mainly by factors such as rising demand for monitoring bodily activities through sensors and increasing the adoption of smart clothes for various end-user industries. Growing …
- アメリカの住宅用煙感知器市場2016-2020About Residential Smoke Detectors Market in the US Smoke detectors are devices that sense smoke and indicate the same through signals or alarms, thereby enhancing residential and commercial security. Residential smoke detectors aid in identifying the presence of fire and inhibit it from spreading. These detectors are connected to an alarm system that emits a high-pitched sound to warn residents of …
- 軌道形状測定システムの世界市場予測：ゲージ、ねじれ、カント量＆カント不足量、鉛直プロファイル、曲率、アライメント、動的水準、ディップジョイントAccording to the MarketsandMarkets forecast, the track geometry measurement system (TGMS) market is expected be worth USD 3.51 Billion by 2022, at a CAGR of 7.88% between 2016 and 2022. The major drivers for the market include increasing need for safety and security in railway transport and growing railway networks and metro lines. In addition, deployment of intelligent and cost-effective techniqu …
- ITセキュリティコンサルティングサービスの世界市場2015-2019About Global IT Security Consulting Services Over the years, enterprises worldwide have become increasingly dependent on technology and internet to run their business and drive revenue growth. This trend is expected to intensify, which means the role of IT departments has become vital and directly contributes to the organization’s agenda. IT integration departments are ensuring measures and upgrad …
- 2014年戦略提言：イタリアの性行為感染症（STD）診断検査市場About This ReportThis new 280-pages report from Venture Planning Group presents detailed analysis of the Italian STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.In addition to market sh …
- Saudi ArabiaのSodium Triphosphate (Sodium Tripolyphosphate)市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of Saudi Arabia and its perspectives on the global market for sodium triphosphate (sodium tripolyphosphate). The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on sodium triphosphate (sodium tripolyphosphate) export/imp …
